K-numberK244018
Device nameDisposable Biopsy Needle
ApplicantZhejiang Curaway Medical Technology Co., Ltd.
Product codeKNW
Device classClass II
Decision dateJul 22, 2025
DecisionSubstantially Equivalent
Regulation876.1075
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Disposable Biopsy Needle is a single-use sterile device intended for obtaining soft tissue biopsies (liver, kidney, breast, thyroid, prostate, spleen, pancreas, lymph nodes, lung, and soft tissue tumors) under imaging guidance. It consists of a cutting cannula, inner stylet, operating handles, depth stopper, and protective sheath, available in five models with different tip types (Chiba or Greene), bevel angles, and various needle gauges and lengths.

Technological characteristics

The subject device differs from predicates in offering two additional needle gauges (17G, 24G), extended needle length options (40–250 mm vs. 50–200 mm), both Chiba and Greene tip types (predicates have Chiba only), polycarbonate operating handles instead of other materials, and expanded anatomical site indications. The subject device is also usable under ultrasound and X-ray but not CT guidance, whereas predicates mention CT.

Test standards cited

ASTM F1980 (packaging/shelf-life), ISO 10993-1, 10993-5, 10993-7, 10993-10, 10993-11, 10993-23 (biocompatibility), ISO 11135:2014 (sterilization validation), and performance testing covering appearance, dimensions, sample collection, Luer connection, stiffness, corrosion resistance, ultrasound/X-ray detectability, puncture force, sterility, and bacterial endotoxin.

Substantial equivalence argument

Both tip designs (Chiba and Greene) achieve puncture via the same combination mechanism of cutting cannula and inner stylet, with performance testing demonstrating no significant difference in sampling weight or cell integrity across all indicated tissues. Additional needle gauges and lengths fall within the dimensional ranges of predicate devices and provide clinically beneficial options without introducing new safety risks. The PC material does not contact patients, and broader anatomical site indications remain within soft tissue scope. Comparative testing across nine tissue types showed substantially equivalent results to predicates.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →